{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:40:17Z","timestamp":1772264417061,"version":"3.50.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["advancesinophthalmology.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Ophthalmology and Optometry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.yaoo.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T02:17:33Z","timestamp":1678069053000},"page":"281-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuro-Ophthalmic Complications of COVID-19 Infection and Vaccination"],"prefix":"10.1016","volume":"8","author":[{"given":"Kholoud","family":"Alotaibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooran","family":"Badeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustum","family":"Karanjia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yaoo.2023.03.004_bib1","unstructured":"World Health Organization, Novel Coronavirus (2019-nCoV): situation report, 11, 2020, World Health Organization, [Internet]. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/330776. Accessed May 20, 2022."},{"key":"10.1016\/j.yaoo.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"n2015","DOI":"10.1136\/bmj.n2015","article-title":"Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: Test negative case-control study","volume":"374","author":"Ranzani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.yaoo.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"n1943","DOI":"10.1136\/bmj.n1943","article-title":"Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: Test negative design study","volume":"374","author":"Chung","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.yaoo.2023.03.004_bib4","doi-asserted-by":"crossref","unstructured":"Bernal J.L., Andrews N., Gower C., et al., Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study, BMJ, 373, 2021, Available at: https:\/\/www.bmj.com\/content\/373\/bmj.n1088. Accessed September 27, 2022.","DOI":"10.1136\/bmj.n1088"},{"key":"10.1016\/j.yaoo.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"103739","DOI":"10.1016\/j.msard.2022.103739","article-title":"COVID-19 vaccine associated demyelination & its association with MOG antibody","volume":"60","author":"Netravathi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.yaoo.2023.03.004_bib6","series-title":"COVID-19 vaccines :safety surveillance manual module : responding to adverse events","year":"2020"},{"key":"10.1016\/j.yaoo.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","article-title":"COVID-19-associated optic neuritis - A case series and review of literature","volume":"70","author":"Jossy","year":"2022","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.yaoo.2023.03.004_bib8","volume":"13","author":"Mabrouki","year":"2021","journal-title":"Acute Blindness as a Complication of Severe Acute Respiratory Syndrome Coronavirus-2, Cureus"},{"issue":"8","key":"10.1016\/j.yaoo.2023.03.004_bib9","first-page":"e16857","article-title":"Post COVID-19 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis","volume":"13","author":"Rojas-Correa","year":"2021","journal-title":"Neuro Ophthalmol"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13365-021-00959-z","article-title":"Optic neuritis following SARS-CoV-2 infection","volume":"27","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2021","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.ajoc.2022.101491","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review","volume":"26","author":"Assavapongpaiboon","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.yaoo.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"103697","DOI":"10.1016\/j.msard.2022.103697","article-title":"Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review","volume":"60","author":"Mirmosayyeb","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/j.yaoo.2023.03.004_bib13","unstructured":"Martinez-Alvarez L, Ning Neo Y, Davagnanam BMedSci FRCR I, et al. Title suggestion: Post vaccination optic neuritis: observations from the SARS-CoV-2 pandemic. Available at: https:\/\/ssrn.com\/abstract=3889990. Accessed June 11, 2022."},{"key":"10.1016\/j.yaoo.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1080\/09273948.2021.1961815","article-title":"Acute Thyroiditis and Bilateral Optic Neuritis following SARS-CoV-2 Vaccination with CoronaVac: A Case Report","volume":"29","author":"Leber","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4103\/ijo.IJO_2374_21","article-title":"Optic neuritis following COVID-19 vaccination: Coincidence or side-effect? - A case series","volume":"70","author":"Roy","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/NDT.S343438","article-title":"Post COVID-19 Vaccination-Associated Neurological Complications","volume":"18","author":"Assiri","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yaoo.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s10072-021-05832-9","article-title":"Bilateral optic neuritis after COVID vaccination","volume":"43","author":"Arnao","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib20","first-page":"1","article-title":"Optic neuropathy after COVID-19 vaccination: a report of two cases","author":"Elnahry","year":"2021","journal-title":"Int J Neurosci"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1159\/000525938","article-title":"Bilateral Optic Neuritis after COVID-19 mRNA Vaccination","volume":"13","author":"Katayama","year":"2022","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/cen3.12682","article-title":"Optic neuritis after COVID-19 vaccine application","volume":"13","author":"Garc\u00eda-Estrada","year":"2022","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib23","unstructured":"Bhatti M.T., Gilbert A.L., Watson G., et al., Shot in the dark. Surv Ophthalmol. Available at: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625722001230. Accessed June 11, 2022."},{"key":"10.1016\/j.yaoo.2023.03.004_bib24","doi-asserted-by":"crossref","unstructured":"Badeeb N., Torres C. and Albreiki D., Case of Bilateral Optic Neuritis With Positive Myelin Oligodendrocyte Glycoprotein Antibody Testing Post-COVID-19 Vaccination, J Neuro Ophthalmol, 2022, Available at: http:\/\/journals.lww.com\/jneuro-ophthalmology. Accessed June 11, 2022.","DOI":"10.1097\/WNO.0000000000001614"},{"key":"10.1016\/j.yaoo.2023.03.004_bib25","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Mediated Optic Neuritis Following COVID-19 Vaccination","author":"Donaldson","year":"2022","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10633-022-09880-0","article-title":"Unilateral optic neuritis after vaccination against the coronavirus disease: two case reports","volume":"145","author":"Wang","year":"2022","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/19418744221090426","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Transverse Myelitis Probably Associated With SARS-CoV-2 mRNA Vaccines: Two Case Reports","volume":"12","author":"Morena","year":"2022","journal-title":"Neurohospitalist"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib28","first-page":"147","article-title":"A\u00a0Case With New-onset Neuromyelitis Optica Spectrum Disorder Following COVID-19 mRNA BNT162b2 Vaccination","volume":"27","author":"Caliskan","year":"2022","journal-title":"Neurol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib29","first-page":"1","article-title":"Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders","author":"Shirah","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.yaoo.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1136\/annrheumdis-2020-218343","article-title":"Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic","volume":"80","author":"Lecler","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib31","first-page":"e933471","article-title":"Arteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19","volume":"23","author":"Szyde\u0142ko-Pa\u015bko","year":"2022","journal-title":"American Journal of Case Reports"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib32","doi-asserted-by":"crossref","first-page":"rkaa067","DOI":"10.1093\/rap\/rkaa067","article-title":"Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19","volume":"4","author":"Luther","year":"2021","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"10.1016\/j.yaoo.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3899\/jrheum.200766","article-title":"Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review","volume":"48","author":"Mehta","year":"2021","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18502\/jovr.v16i3.9443","article-title":"COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: Real or coincidence?","volume":"16","author":"Maleki","year":"2021","journal-title":"J\u00a0Ophthalmic Vis Res"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib35","first-page":"e25388","article-title":"A\u00a0Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination","volume":"14","author":"Xia","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.yaoo.2023.03.004_bib36","article-title":"Bilateral Ischemic Optic Neuropathy From Giant Cell Arteritis Following COVID-19 Vaccination","author":"Che","year":"2022","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12886-021-02028-9","article-title":"Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome","volume":"21","author":"Clarke","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/01658107.2021.1909075","article-title":"Non-Arteritic Anterior Ischaemic Optic Neuropathy with Progressive Macular Ganglion Cell Atrophy due to COVID-19","volume":"46","author":"Y\u00fcksel","year":"2022","journal-title":"Neuro Ophthalmol"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4103\/ijo.IJO_2365_21","article-title":"Bilateral sequential non-arteritic optic neuropathy post-COVID-19","volume":"70","author":"Sanoria","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib40","doi-asserted-by":"crossref","first-page":"101684","DOI":"10.1016\/j.ajoc.2022.101684","article-title":"Non-arteritic anterior ischemic optic neuropathy in COVID-19 infection \u2013 A case report","volume":"27","author":"Sitaula","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.yaoo.2023.03.004_bib41","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.jfo.2021.12.001","article-title":"Non-arteritic anterior ischemic optic neuropathy as an atypical feature of COVID-19: A case report","volume":"45","author":"Babazadeh","year":"2022","journal-title":"J\u00a0Fr Ophtalmol"},{"issue":"12","key":"10.1016\/j.yaoo.2023.03.004_bib42","first-page":"e11950","article-title":"A\u00a0Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19","volume":"12","author":"Rho","year":"2020","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.yaoo.2023.03.004_bib43","first-page":"e5126254","article-title":"Non-Arteritic Anterior Ischemic Optic Neuropathy Following COVID-19 Vaccination","volume":"10","author":"Lin","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.yaoo.2023.03.004_bib44","first-page":"1","article-title":"Nonarteritic Anterior Ischemic Optic Neuropathy following COVID-19 Vaccination: Consequence or Coincidence","volume":"2021","author":"Tsukii","year":"2021","journal-title":"Case Rep Ophthalmol Med"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib45","first-page":"e935095","article-title":"Ischemic Optic Neuropathy After Administration of a SARS-CoV-2 Vaccine: A Report of 2 Cases","volume":"23","author":"Franco","year":"2022","journal-title":"American Journal of Case Reports"},{"key":"10.1016\/j.yaoo.2023.03.004_bib46","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/09273948.2022.2059522","article-title":"Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination","volume":"30","author":"Elhusseiny","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.yaoo.2023.03.004_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3341\/kjo.2021.0128","article-title":"Nonarteritic Anterior Ischemic Optic Neuropathy Following COVID-19 Vaccination: A Case Report","volume":"36","author":"Chung","year":"2022","journal-title":"Kor J Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib48","doi-asserted-by":"crossref","unstructured":"Nachbor KM, Naravane AV, Adams OE, et al. Nonarteritic Anterior Ischemic Optic Neuropathy Associated With COVID-19 Vaccination. Available at: http:\/\/links.lww.com\/WNO\/A525. Accessed April 12, 2022.","DOI":"10.1097\/WNO.0000000000001423"},{"issue":"13","key":"10.1016\/j.yaoo.2023.03.004_bib49","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0333102420965963","article-title":"Isolated intracranial hypertension associated with COVID-19","volume":"40","author":"Silva","year":"2020","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib50","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/IOP.0000000000002136","article-title":"Vision Loss Secondary to COVID-19 Associated Bilateral Cerebral Venous Sinus Thromboses","volume":"38","author":"Omari","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.yaoo.2023.03.004_bib51","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amj.2022.07.007","article-title":"Intracranial Hypertension and Papilledema: An Unusual Complication After the Adenoviral DNA Vector\u2013Based Coronavirus Disease 2019 Vaccination in an Air Medical Transportation Pilot","volume":"41","author":"Farahani","year":"2022","journal-title":"Air Med J"},{"key":"10.1016\/j.yaoo.2023.03.004_bib52","first-page":"4","article-title":"Isolated intracranial hypertension following COVID-19 vaccination: A case report","author":"Thunstedt","year":"2021","journal-title":"Cephalalgia Rep"},{"key":"10.1016\/j.yaoo.2023.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221074450","article-title":"Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review","volume":"13","author":"Jaiswal","year":"2022","journal-title":"J Prim Care Community Health"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MBC.0000000000001113","article-title":"Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis","volume":"33","author":"Matar","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.yaoo.2023.03.004_bib55","first-page":"39","article-title":"COVID-19 associated cranial nerve neuropathy: A systematic review","volume":"22","author":"Finsterer","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib56","doi-asserted-by":"crossref","unstructured":"Cicalese M.P., Ferrua F., Barzaghi F., et al., Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: Change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response, BMJ Case Rep, 15 (2), 2022,e246485.","DOI":"10.1136\/bcr-2021-246485"},{"key":"10.1016\/j.yaoo.2023.03.004_bib57","article-title":"Presumed oculomotor nerve palsy following COVID-19 vaccination","volume":"10","author":"Kerbage","year":"2022","journal-title":"SAGE Open Med Case Rep"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/01658107.2022.2032204","article-title":"Facial and Abducens Nerve Palsies Following COVID-19 Vaccination: Report of Two Cases","volume":"46","author":"Veisi","year":"2022","journal-title":"Neuro Ophthalmol"},{"issue":"12","key":"10.1016\/j.yaoo.2023.03.004_bib59","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.4103\/ijo.IJO_1968_21","article-title":"Acute abducens nerve palsy after COVID-19 vaccination in a young adult","volume":"69","author":"Pawar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaapos.2021.05.003","article-title":"Acute abducens nerve palsy following COVID-19 vaccination","volume":"25","author":"Reyes-Capo","year":"2021","journal-title":"Journal of AAPOS"},{"key":"10.1016\/j.yaoo.2023.03.004_bib61","doi-asserted-by":"crossref","first-page":"104434","DOI":"10.1016\/j.amsu.2022.104434","article-title":"Isolated abducens nerve palsy following AstraZeneca vaccine: A case report","volume":"81","author":"Basnet","year":"2022","journal-title":"Annals of Medicine and Surgery"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib62","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/01658107.2022.2037661","article-title":"Inflammatory Sixth Nerve Palsy Post-COVID-19 Vaccination: Magnetic Resonance Imaging Findings","volume":"46","author":"Karam","year":"2022","journal-title":"Neuro Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib63","article-title":"Binocular Horizontal Diplopia Following mRNA-1273 Vaccine","author":"Mahgerefteh","year":"2022","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib64","first-page":"e14","article-title":"Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine","volume":"43","author":"Pappaterra","year":"2023","journal-title":"J\u00a0Neuro Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ane.13548","article-title":"Multiple cranial nerve palsies following COVID-19 vaccination\u2014Case report","volume":"145","author":"Manea","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12883-022-02900-1","article-title":"A\u00a0case report of unilateral cervical lymphadenopathy and multiple cranial neuropathies following mRNA-COVID-19 vaccination","volume":"22","author":"Shalabi","year":"2022","journal-title":"BMC Neurol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/ICU.0000000000000904","article-title":"Efferent neuro-ophthalmic complications of coronavirus disease 2019","volume":"33","author":"Dinkin","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"issue":"17","key":"10.1016\/j.yaoo.2023.03.004_bib68","doi-asserted-by":"crossref","first-page":"20939","DOI":"10.1007\/s11356-021-13233-w","article-title":"Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review","volume":"28","author":"Li","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib69","first-page":"e24638","article-title":"COVID-19-Associated Miller Fisher Syndrome With Long Latency Period: A Case Report","volume":"14","author":"Kuang","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s13760-021-01787-y","article-title":"SARS-CoV-2-associated Guillain\u2013Barr\u00e9 syndrome in four patients: what do we know about pathophysiology?","volume":"122","author":"Guilmot","year":"2022","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12883-022-02838-4","article-title":"A\u00a0case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report","volume":"22","author":"Nanatsue","year":"2022","journal-title":"BMC Neurol"},{"issue":"11","key":"10.1016\/j.yaoo.2023.03.004_bib72","doi-asserted-by":"crossref","first-page":"e246701","DOI":"10.1136\/bcr-2021-246701","article-title":"Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination","volume":"14","author":"Dang","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12883-021-02489-x","article-title":"Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination","volume":"21","author":"Nishiguchi","year":"2021","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1016\/j.yaoo.2023.03.004_bib74","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2169\/internalmedicine.8851-21","article-title":"Miller Fisher Syndrome Following Vaccination against SARS-CoV-2","volume":"61","author":"Yamakawa","year":"2022","journal-title":"Internal Medicine"},{"issue":"20","key":"10.1016\/j.yaoo.2023.03.004_bib75","first-page":"e29333","article-title":"Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature","volume":"101","author":"Siddiqi","year":"2022","journal-title":"Medicine (United States)"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/CND.0000000000000376","article-title":"Miller Fisher Syndrome Presenting After a Second Dose of Pfizer-BioNTech Vaccination in a Patient With Resolved COVID-19_ A Case Report","volume":"23","author":"Michaelson","year":"2021","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib77","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ane.13687","article-title":"Miller Fisher syndrome following COVID-19 vaccines: A scoping review","volume":"146","author":"Kim","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib78","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10072-021-05776-0","article-title":"Miller Fisher syndrome following Pfizer COVID-19 vaccine","volume":"43","author":"Abi\u010di\u0107","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib79","doi-asserted-by":"crossref","unstructured":"Brossard-Barbosa N., Donaldson L., Margolin E., et al., Seropositive Ocular Myasthenia Gravis Developing Shortly After COVID-19 Infection: Report and Review of the Literature Clinical Correspondence, J Neuro Ophthalmol, 2022, Available at: http:\/\/links.lww. Accessed June 27, 2023.","DOI":"10.1097\/WNO.0000000000001586"},{"issue":"8","key":"10.1016\/j.yaoo.2023.03.004_bib80","doi-asserted-by":"crossref","first-page":"e244102","DOI":"10.1136\/bcr-2021-244102","article-title":"Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection","volume":"14","author":"Essajee","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.yaoo.2023.03.004_bib81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2022.02.046","article-title":"New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children","volume":"245","author":"Yavuz","year":"2022","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yaoo.2023.03.004_bib82","doi-asserted-by":"crossref","first-page":"576153","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient","volume":"11","author":"Huber","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib83","first-page":"2690","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava","year":"2021","journal-title":"J\u00a0Neurol"},{"issue":"15","key":"10.1016\/j.yaoo.2023.03.004_bib84","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1212\/WNL.96.15_supplement.4382","article-title":"Myasthenia Gravis After SARS-CoV-2 Infection: A Cerner Real-World COVID-19 De-identified Dataset Analysis","volume":"96","author":"Patlolla","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.yaoo.2023.03.004_bib85","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1007\/s10072-022-06284-5","article-title":"New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series","volume":"43","author":"Fanella","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib86","doi-asserted-by":"crossref","first-page":"120225","DOI":"10.1016\/j.jns.2022.120225","article-title":"Flare of myasthenia gravis induced by COVID-19 vaccines","volume":"436","author":"Ishizuchi","year":"2022","journal-title":"J\u00a0Neurol Sci"},{"issue":"10","key":"10.1016\/j.yaoo.2023.03.004_bib87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nmd.2022.09.001","article-title":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature","volume":"32","author":"Ramdas","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.yaoo.2023.03.004_bib88","first-page":"e27213","article-title":"New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine","volume":"14","author":"Abicic","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.yaoo.2023.03.004_bib89","doi-asserted-by":"crossref","unstructured":"Slavin E., Fitzig J., Neubert C., et al., New-Onset Myasthenia Gravis Confirmed by Electrodiagnostic Studies After a Third Dose of SARS-CoV-2 mRNA-1273 Vaccine, Am J Phys Med Rehabil, 101 (12), 2022, e176\u2013e179, Available at: https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002076. Accessed May 12, 2022.","DOI":"10.1097\/PHM.0000000000002076"},{"key":"10.1016\/j.yaoo.2023.03.004_bib90","doi-asserted-by":"crossref","first-page":"101620","DOI":"10.1016\/j.ajoc.2022.101620","article-title":"Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report","volume":"27","author":"Kang","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"8","key":"10.1016\/j.yaoo.2023.03.004_bib91","first-page":"003439","article-title":"Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine","volume":"9","author":"Hoshina","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.yaoo.2023.03.004_bib92","article-title":"New-Onset Myasthenia Gravis After ChAdOx1 nCOV-19 Vaccine Inoculation","author":"Huang","year":"2022","journal-title":"J Neuro Ophthalmol"},{"issue":"7","key":"10.1016\/j.yaoo.2023.03.004_bib93","article-title":"Early-Onset Myasthenia Gravis Following COVID-19 Vaccination","volume":"37","author":"Lee","year":"2022","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib94","first-page":"1","article-title":"Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine","author":"Maher","year":"2022","journal-title":"Orbit"},{"key":"10.1016\/j.yaoo.2023.03.004_bib95","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s40618-022-01786-7","article-title":"Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence","volume":"45","author":"Jafarzadeh","year":"2022","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.yaoo.2023.03.004_bib96","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/IOP.0000000000002059","article-title":"Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves\u2019 Disease: A Case Report","volume":"37","author":"Rubinstein","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/tjo.tjo_61_21","article-title":"Thyroid eye disease reactivation associated with COVID-19 vaccination","volume":"12","author":"Park","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib98","first-page":"1","article-title":"Orbital Inflammatory Pseudotumor following mRNA COVID-19 Vaccination","author":"Yucel Gencoglu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.yaoo.2023.03.004_bib99","first-page":"970","article-title":"Concurrent tonic pupil and trochlear nerve palsy in COVID-19","volume":"6","author":"Ord\u00e1s","year":"2022","journal-title":"J\u00a0Neurovirol"},{"issue":"4","key":"10.1016\/j.yaoo.2023.03.004_bib100","first-page":"e764","article-title":"Tonic Pupil Following COVID-19","volume":"41","author":"Gopal","year":"2021","journal-title":"J\u00a0Neuro Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib101","article-title":"Adie Pupil After BNT162b2 mRNA COVID-19 Vaccine","author":"G\u00f6n\u00fcltas\u00b8","year":"2022","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib102","doi-asserted-by":"crossref","first-page":"100349","DOI":"10.1016\/j.ensci.2021.100349","article-title":"Transient Horner syndrome associated with COVID-19: A case report","volume":"25","author":"Naor","year":"2021","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.yaoo.2023.03.004_bib103","doi-asserted-by":"crossref","first-page":"102857","DOI":"10.1016\/j.msard.2021.102857","article-title":"MOG-associated encephalitis following SARS-COV-2 infection","volume":"50","author":"Peters","year":"2021","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"7","key":"10.1016\/j.yaoo.2023.03.004_bib104","doi-asserted-by":"crossref","first-page":"102556","DOI":"10.1016\/j.autrev.2020.102556","article-title":"Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons","volume":"19","author":"Lucchese","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.yaoo.2023.03.004_bib105","series-title":"Infectious optic neuropathies: a clinical update","first-page":"59","author":"Kahloun","year":"2015"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib106","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4103\/ijo.IJO_3589_20","article-title":"Adie-Holmes syndrome associated with COVID-19 infection: A case report","volume":"69","author":"Kaya Tutar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"10.1016\/j.yaoo.2023.03.004_bib107","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.yaoo.2023.03.004_bib108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.medcli.2020.11.005","article-title":"SARS-CoV-2 infection triggering a giant cell arteritis","volume":"156","author":"Riera-Marti","year":"2021","journal-title":"Med Clin"},{"issue":"3","key":"10.1016\/j.yaoo.2023.03.004_bib109","first-page":"398","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"J\u00a0Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.yaoo.2023.03.004_bib110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12931-020-01462-5","article-title":"The pathophysiology of \u201chappy\u201d hypoxemia in COVID-19","volume":"21","author":"Dhont","year":"2020","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.yaoo.2023.03.004_bib111","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.yaoo.2023.03.004_bib112","first-page":"e145","article-title":"Granuloma Annulare, Scalp Necrosis, and Ischemic Optic Neuropathy From Giant Cell Arteritis After Varicella-Zoster Virus Vaccination","volume":"41","author":"Nichani","year":"2021","journal-title":"J\u00a0Neuro Ophthalmol"},{"key":"10.1016\/j.yaoo.2023.03.004_bib113","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.autrev.2013.03.012","article-title":"A\u00a0literature review on optic neuritis following vaccination against virus infections","volume":"12","author":"St\u00fcbgen","year":"2013","journal-title":"Autoimmun Rev"}],"container-title":["Advances in Ophthalmology and Optometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452176023000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452176023000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:46:19Z","timestamp":1762530379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452176023000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2452176023000239"],"URL":"https:\/\/doi.org\/10.1016\/j.yaoo.2023.03.004","relation":{},"ISSN":["2452-1760"],"issn-type":[{"value":"2452-1760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-Ophthalmic Complications of COVID-19 Infection and Vaccination","name":"articletitle","label":"Article Title"},{"value":"Advances in Ophthalmology and Optometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yaoo.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}